# NAGLAZYME

NDC: 68135-020
Generic name: galsulfase
Labeler / Manufacturer: BioMarin Pharmaceutical Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20050609

FDA application: BLA125117

## Active ingredients

- GALSULFASE: 5 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68135-020"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68135-020
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59341250-deac-ed71-3823-a4f5d64dbd77